LLY

Eli Lilly and Company Healthcare - Pharmaceuticals Investor Relations →

NO
83.0% ABOVE
↑ Moving away Was 72.7% last week
-15% -10% -5% 0% 5% 10% 15%+
Signal Threshold $788.64
14-Week RSI 67
Rel. Volume (14w) This week's trading vs. the 14-week average 1.2x
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 1.04

Eli Lilly and Company (LLY) closed at $1443.50 as of 2026-11-13, trading 83.0% above its 200-week moving average of $788.64. The stock moved further from the line this week, up from 72.7% last week. The 14-week RSI sits at 67, indicating neutral momentum.

Trading volume is running at 1.2x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.04 ratio) is neutral — neither side is clearly dominating.

Over the past 2793 weeks of data, LLY has crossed below its 200-week moving average 23 times. On average, these episodes lasted 34 weeks. The average one-year return after crossing below was -0.9%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $1.3 trillion, LLY is a mega-cap stock. The company generates a free cash flow yield of 0.7%. Return on equity stands at 86.0%, indicating strong profitability. The stock trades at 31.9x book value.

The company has been aggressively buying back shares, reducing its share count by 5.8% over the past three years.

Over the past 33.9 years, a hypothetical investment of $100 in LLY would have grown to $24904, compared to $3136 for the S&P 500. That represents an annualized return of 17.7% vs 10.7% for the index — confirming LLY as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.

Free cash flow has been growing at a 9% compound annual rate, with 2 consecutive years of positive cash generation.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: LLY vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After LLY Crosses Below the Line?

Across 11 historical episodes, buying LLY when it crossed below its 200-week moving average produced an average return of -7.8% after 12 months (median -10.0%), compared to -2.4% for the S&P 500 over the same periods. 18% of those episodes were profitable after one year. After 24 months, the average return was -10.5% vs -1.5% for the index.

Each line shows $100 invested at the moment LLY crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices LLY would reach each dislocation threshold.

Current Bean Score -2.17σ
Current FCF Yield 0.91%
Baseline Yield 1.15%
Historical σ 0.10pp

Dislocation Price Levels

Prices where LLY's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-09-30).

LevelσPriceSignal
Deep Value+2σ$981.01Unusually cheap — analysis point
Value+1σ$1062.59Cheap vs. own history
Fair Value+0σ$1158.96Historical mean behavior
Expensive-1σ$1274.57Expensive vs. own history
Deep Expensive-2σ$1415.79Unusually expensive — analysis point

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Recent Earnings

DateEPS Est.EPS ActualSurprise
2026-10-29$6.35$7.48+17.9%
2026-08-05$6.58$8.38+27.3%
2026-04-30$6.79$8.55+25.9%
2026-02-04$6.91$7.54+9.1%
Data depth: 2 quarterly baselines, 19 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

21 / 13 weeks minimum

the write-ups I read Simply Wall St · Visual company reports and write-ups. Free tier covers five reports a month. referral

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are analysis points: prices at which the yield deviation becomes unusual enough to justify the work. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from LLY's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

Yield Dislocation -1.30σ Dividend yield vs own 10-yr norm
Drawdown Score -1.36σ Distance from line vs own history
Sector-Relative -0.99σ Vs sector median this week
Buyback Acceleration +1.7pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity N/A TTM buys / market cap, percentile of buyers
FCF Yield vs History +0.7pp Vs own recent annual mean
Earnings Quality Stable Accrual gap trend (-1.1pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. Each one is an analysis point, a reason to open the filings. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Historical Touches

LLY has crossed below its 200-week MA 23 times with an average 1-year return of +-0.9% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Aug 1973Sep 197338.2%-16.0%+136442.7%
Oct 1973Oct 197310.9%-24.8%+134233.3%
Nov 1973Jun 19742721.2%-8.1%+133898.2%
Jul 1974Feb 19753323.9%+7.1%+137929.2%
Mar 1975May 197578.9%-23.2%+141858.4%
Jul 1975Jul 197815839.4%-25.2%+138896.8%
Sep 1978Sep 197810.1%+28.8%+192828.0%
Oct 1978Dec 1978911.1%+24.0%+205222.6%
Sep 1981Sep 198115.1%+21.4%+175241.1%
Oct 1981Oct 198112.8%+24.4%+170218.3%
Aug 1982Aug 198239.8%+39.0%+170065.8%
Jul 1984Jul 198421.6%+71.3%+133624.7%
Sep 1992Oct 199410731.3%-17.6%+22257.4%
Feb 2000Mar 200034.3%+26.4%+4870.1%
Jan 2002Feb 200242.2%-10.1%+3707.2%
Apr 2002Nov 20038435.8%-17.0%+3653.3%
Nov 2003Dec 200320.3%-18.7%+3863.2%
Jan 2004Feb 200442.6%-14.9%+3934.7%
Mar 2004Apr 200446.2%-21.6%+3854.1%
Jul 2004Oct 200611722.1%-13.9%+3930.8%
Oct 2006Apr 2007249.4%-4.8%+4350.5%
Jul 2007Aug 200722.9%-10.1%+4410.3%
Oct 2007Apr 201118341.4%-37.5%+4575.7%
Average34—+-0.9%—

Frequently Asked Questions

Is LLY below its 200-week moving average?

No. Eli Lilly and Company (LLY) is currently 83.0% above its 200-week moving average of $788.64. It would need to fall to $788.64 to cross below the line.

What is LLY's 200-week moving average price?

Eli Lilly and Company's 200-week moving average is $788.64 as of 2026-11-13. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when LLY drops below its 200-week moving average?

LLY has crossed below its 200-week moving average 23 times in our data. The average one-year return after these crossings was -0.9%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 34 weeks on average.

Is LLY a good value right now?

Here's what our data says about LLY as of 2026-11-13: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 67. Free cash flow yield is 0.7%. Return on equity is 86.0%. Price-to-book is 31.9x. This is not a buy or sell recommendation — always do your own research.

How does LLY compare to the S&P 500?

Over the past 33.9 years, $100 invested in LLY would have grown to $24904, compared to $3136 for the S&P 500. That's 17.7% annualized vs 10.7% for the index. LLY has outperformed the broader market over this period.

Does LLY pay a dividend?

Yes. Eli Lilly and Company currently pays a dividend yield of 48.00%.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-11-13